SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Hospice and Palliative Medicine®
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Miller, K. E.
Right arrow Articles by Miller, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, K. E.
Right arrow Articles by Miller, M. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Antidepressant medication use in palliative care

Karl E. Miller, MD

Department of Family Medicine, Chattanooga Unit, University of Tennessee COM, Chattanooga, Tennessee

Stephen M. Adams, MD

Department of Family Medicine, Chattanooga Unit, University of Tennessee COM, Chattanooga, Tennessee

Martha M. Miller, RN

Adventa Hospice, Chattanooga, Tennessee

Depression and other mood disorders occur in approximately 25 percent of terminal patients. Untreated, depression and mood disorders can have a significantly negative impact on patients andfamilies. Screeningfor depression can be done as easily as asking one question: "Areyou depressed?" A positive response to this question can be followed with one of the more extensive screening tools. Anxiety disorders can also have a negative effect on patients and their families. These can be identified by also using one of the validated screening tools. Use of the antidepressant medications for treating depression and, in some cases, anxiety disorders has not been well studied in hospice and palliative care. Some of the antidepressants can also serve as adjuvant therapy in pain management.

Key Words: depression • antidepressant medication • hospice • palliative care

References

  • 1. Lloyd-Williams M, Dennis M, Taylor F: A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med. 2004; 18: 558-563.[Abstract/Free Full Text]
  • 2. Le Fevre P, Devereux J, Smith S, et al.: Screening for psychiatric illness in the palliative care inpatient setting: A comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med. 1999; 13: 399-407.[Abstract/Free Full Text]
  • 3. Akechi T, Okuyama T, Sugawara Y, et al.: Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: Associated and predictive factors. J Clin Oncol. 2004; 22: 1957-1965.[Abstract/Free Full Text]
  • 4. Lloyd-Williams M, Friedman T, Rudd N: A survey of antidepressant prescribing in terminally ill. Palliat Med. 1999; 13: 243-248.[Abstract/Free Full Text]
  • 5. Block SD: Assessing and managing depression in the terminally ill patient. Ann Intern Med. 2000; 132: 209-218.[Abstract/Free Full Text]
  • 6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000, p 356-356.
  • 7. Periyakoil VS, Hallenbeck J: Identifying and managing preparatory grief and depression at the end of life. Am Fam Physician. 2002; 65: 883-890.[Medline] [Order article via Infotrieve]
  • 8. Lloyd-Williams M, Spiller J, Ward J: Which depression screening tools should be used in palliative care? Palliat Med. 2003; 17: 40-43.[Abstract/Free Full Text]
  • 9. Lloyd-Williams M, Dennis M, Taylor F, et al.: Is asking patients in palliative care, "Are you depressed?" appropriate? Prospective study. BMJ. 2003; 327: 372-373.[Free Full Text]
  • 10. Holtom N, Barraclough J: Is the Hospital Anxiety and Depression Scale (HADS) useful in assessing depression in palliative care? Palliat Med 2000; 14: 219-220.[Free Full Text]
  • 11. Lloyd Williams M: Is appropriate to screen palliative care patients for depression? Am JHosp Palliat Care. 2002; 19(2): 112-114.
  • 12. Lloyd-Williams M, Dennis M, Taylor F: A prospective study to compare three depression screening tools in patients who are terminally ill. Gen Hosp Psychiatry. 2004; 26: 384-389.[CrossRef][Medline] [Order article via Infotrieve]
  • 13. Lloyd-Williams M: Difficulties in diagnosing and treating depression in the terminally ill cancer patient. Postgrad Med 2000; 76: 555-558.[Abstract/Free Full Text]
  • 14. Hoyl MT, Alessi CA, Harker JO, et al.: Development and testing of a five-item version of the Geriatric Depression Scale. JAm Geriatr Soc. 1999; 47: 873-878.[Medline] [Order article via Infotrieve]
  • 15. Chochinov HM, Wilson KG, Enns M, et al.: Desire for death in the terminally ill. Am JPsychiatry. 1995; 152: 1185-1191.
  • 16. Grov EK, Dahl AA, Fossa SD: Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase. Ann Oncol. 2005; 16(7): 1185-1191.[Abstract/Free Full Text]
  • 17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000, p 479-479.
  • 18. Barraclough J: ABC of palliative care: Depression, anxiety and confusion. BMJ. 1997; 315(22 November): 1365-1368.[Free Full Text]
  • 19. Potter WZ, Hollister LE: Antidepressant agents. In: Katzung BG (ed): Basic and Clinical Pharmacology, ed 9. New York: McGraw-Hill, 2003,482-495.
  • 20. Nelson JC: Tricyclic and heterocyclic drugs. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, ed 3. Washington, DC: American Psychiatric Publishing, 2004, pp 207-230.
  • 21. Furukawa T, McGuire H, Barbui C: Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev. 2003(3).
  • 22. Rosenbaum JF, Tollefson GD: Fluoxetine. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, ed 3. Washington, DC: American Psychiatric Publishing, 2004, 231-236.
  • 23. Herr KD, Nemeroff CB: Paroxetine. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, ed 3. Washington, DC: American Psychiatric Publishing, 2004, 259-282.
  • 24. Abramowicz M (ed): Which SSRI? Med Lett Drugs Ther 2003; 45(1170).
  • 25. Bernard SA: The interaction of medications used in palliative care. Hematol Oncol Clin North Am. 2002; 16: 641-655.[CrossRef][Medline] [Order article via Infotrieve]
  • 26. Micromedex Healthcare Series Vol. 125. Expires 9/2005. Accessed August 26, 2005.
  • 27. Saiz-Ruiz J, Ibanez A, Diaz-Marsa M, et al.: Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(6): 1129-1134.[CrossRef][Medline] [Order article via Infotrieve]
  • 28. Detke MJ, Wiltse CG, Mallinckrodt CH, et al.: Duloxetine in the acute and long-term treatment of major depressive disorder: A placebo- and paroxetine-based controlled trial. Eur Neuropsychopharmacol. 2004; 14(6): 457-470.[CrossRef][Medline] [Order article via Infotrieve]
  • 29. Golden RN, Dawkins K, Nicholas L: Trazodone and nefazodone. In: Schatzberg AF, Nemeroff,CB (eds): The American Psychiatric Publishing Textbook of Psychopharmacology, ed 3. Washington, DC: American Psychiatric Publishing, 2004, 315-325.
  • 30. Martinon-Torres G, Fioravanti M, Grimley Evans J: Trazodone for agitation in dementia. Cochrane Database Syst Rev. 2004(3): CD004990.
  • 31. Williams JW, Mulrow CD, Chiquette E, et al.: Clinical guideline, part 2. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary. Ann Intern Med. 2000; 132: 743-756.[Abstract/Free Full Text]
  • 32. Guaiana G, Barbui C, Hotopf M: Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database of Syst Rev. 2003(2).
  • 33. Roose SP, Laghrissi-Thode F, Kennedy JS, et al.: Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAM4. 1998; 279: 287-291.[Abstract/Free Full Text]
  • 34. Snow V, Lascher S, Mottur-Pilson C: Clinical guideline 1: Pharmacologic treatment of acute major depression and dysthymia. Ann Intern Med 2000; 132: 738-742.[Free Full Text]
  • 35. Furukawa TA, Streiner DL, Young LT: Antidepressants and benzodiazepine for major depression. Cochrane Database Syst Rev. 2001(3).
  • 36. Potash M, Breitbart W: Affective disorders in advanced cancer. Hematol Oncol Clin North Am. 2002; 16: 671-700.[CrossRef][Medline] [Order article via Infotrieve]
  • 37. Lynch ME: Antidepressants and analgesics: A review of randomized controlled trials. J Psychiatry Neurosci. 2001; 26(1): 30-36.[Medline] [Order article via Infotrieve]
  • 38. Saarto T, Wiffen PJ: Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005(3)CD005454.
  • 39. Dworkin RH, Backonja M, Rowbotham MC, et al.: Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003; 60: 1524-1534.[Abstract/Free Full Text]
  • 40. Sindrup SH, Bach FW, Madsen C, et al.: Venlafaxine versus imipramine in painful polyneuropathy: A randomized trial. Neurology. 2003; 60(8): 1284-1289.[Abstract/Free Full Text]
  • 41. Goldstein DJ, Lu Y, Detke MJ, et al.: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005; 116(1-2): 109-118.[CrossRef][Medline] [Order article via Infotrieve]
  • 42. Leo RJ, Barkin RL: Antidepressant use in chronic pain management: Is there a role for duloxetine? Prim Care Comp J Clin Psychiatry. 2003; 5: 118-123.

American Journal of Hospice and Palliative Medicine®, Vol. 23, No. 2, 127-133 (2006)
DOI: 10.1177/104990910602300210
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 AM J HOSP PALLIAT CAREHome page
R. R. Ali, K. M. Winkfield, and A. N. Galanos
Letter to the Editor
American Journal of Hospice and Palliative Medicine, August 1, 2006; 23(4): 267 - 268.
[PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Miller, K. E.
Right arrow Articles by Miller, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, K. E.
Right arrow Articles by Miller, M. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement